+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Virus-like Particles Delivery System Market - Global Forecast 2025-2030- Product Image
Virus-like Particles Delivery System Market - Global Forecast 2025-2030- Product Image
Sale

Virus-like Particles Delivery System Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6131164
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Virus-like particle delivery systems are redefining therapeutic innovation by merging the complex architecture of viruses with enhanced clinical safety. This executive overview offers senior decision-makers a concise, strategic analysis of market drivers, technology advancements, segmentation, and actionable insights shaping the competitive landscape for virus-like particle (VLP) platforms.

Market Snapshot

The virus-like particle delivery market is experiencing significant momentum, propelled by advancements in structural biology, refined manufacturing processes, and growing demand for targeted therapies. Notably, enhanced expression systems have improved yields and purity, while streamlined purification protocols and modular engineering capabilities position these platforms as a central solution in gene therapy, vaccines, and advanced biologics applications. As companies accelerate their innovation pipelines, these systems are poised for continued advancement across key regional clusters and specialized application areas.

Scope & Segmentation

This report comprehensively examines the evolving landscape by segmenting the market across multiple strategic dimensions:

  • Applications: Cancer immunotherapy, drug delivery, gene therapy, prophylactic vaccines, and therapeutic vaccines.
  • VLP Type: Bacterial, insect, mammalian, and plant-derived platforms.
  • Delivery Route: Nasal, oral, and parenteral methods, including intramuscular, intravenous, and subcutaneous administration.
  • End Users: Hospitals and clinics, pharmaceutical and biotech companies, academic research institutes, and contract research organizations.
  • Regional Coverage: Americas (with focus on United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (including United Kingdom, Germany, France, and other major countries), and Asia-Pacific (highlighting China, India, Japan, Australia, and additional key markets).
  • Company Profiles: Analysis of industry leaders such as Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Danaher Corporation, Catalent, Inc., Fujifilm Diosynth Biotechnologies U.S.A., Inc., Boehringer Ingelheim International GmbH, Wacker Biotech GmbH, Evonik Industries AG, and BioVectra Inc.

Key Takeaways – Virus-Like Particle Delivery Platforms

  • Virus-like particle delivery platforms leverage modular capsid proteins to achieve precision in surface modification, antigen display, and payload encapsulation for diverse therapeutic needs.
  • Regulatory bodies are tailoring evaluation protocols for these advanced platforms, reflecting a shift from legacy frameworks used for traditional biologics and live attenuated vaccines.
  • Collaborative models—including public-private partnerships and alliances between academic laboratories and manufacturers—are accelerating early clinical validation and commercial scalability.
  • Differentiated VLP origins, whether bacterial, insect, mammalian, or plant-based, influence production scalability, immunogenicity, and downstream processing requirements for each application segment.
  • The expansion of end-to-end manufacturing and analytical capabilities by leading providers supports seamless project transitions from research through clinical supply, answering evolving customer requirements.

Tariff Impact

Recent changes in United States tariff policies have introduced new challenges for the VLP delivery supply chain. Duties on raw materials and bioprocessing equipment are increasing landed input costs and prompting manufacturers to diversify suppliers, reevaluate sourcing, and prioritize domestic or near-shore production. These adjustments are impacting operational budgets and capacity planning, while spurring investment in digital supply chain platforms and cross-border collaborations to ensure business continuity and logistical resilience. Organizations are also initiating dialogue with regulatory agencies to mitigate potential effects on production timelines and product registration.

Methodology & Data Sources

This analysis is grounded in primary interviews with senior scientific, manufacturing, and regulatory experts, bolstered by secondary research from peer-reviewed journals, patent filings, and industry events. Data triangulation and iterative review cycles with subject matter advisors ensure accuracy and depth, providing a robust foundation for all strategic findings.

Why This Report Matters

  • Provides actionable clarity for C-suite, regulatory, and R&D leaders aiming to prioritize investment or partnership decisions in dynamic VLP markets.
  • Uncovers implications of evolving policy and supply trends on operational, procurement, and long-term product development strategy.
  • Equips stakeholders with an evidence-backed roadmap to navigate complex technological, regulatory, and global market shifts.

Conclusion

Virus-like particle delivery systems are enabling new therapeutic frontiers by integrating scientific, operational, and commercial innovation. Organizations adopting resilient supply strategies and fostering regional and cross-sector collaborations will be best positioned to capitalize on emerging opportunities in this rapidly evolving field.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in scalable cell-free expression systems for VLP manufacturing to reduce production costs and boost yield
5.2. Integration of virus-like particle platforms with mRNA delivery to enhance targeted antigen presentation in oncology vaccines
5.3. Innovations in cryogenic storage and lyophilization techniques extending the shelf life of virus-like particle formulations
5.4. Development of modular VLP scaffolds for multivalent antigen display to broaden protective immune responses
5.5. Strategic partnerships between biopharma companies and CDMOs accelerating commercial VLP vaccine production pipelines
5.6. Regulatory guidelines evolution for VLP-based therapeutics streamlining approval processes across major markets
5.7. Advances in targeted delivery of VLPs via ligand modification to optimize tissue-specific immunogenicity
5.8. Emergence of self-amplifying RNA encapsulated within VLPs enabling dose sparing in next-generation vaccines
5.9. Adoption of single-use bioreactors in VLP manufacturing enhancing process flexibility and contamination control
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Virus-like Particles Delivery System Market, by Application
8.1. Introduction
8.2. Cancer Immunotherapy
8.3. Drug Delivery
8.4. Gene Therapy
8.5. Vaccine
8.5.1. Prophylactic Vaccine
8.5.2. Therapeutic Vaccine
9. Virus-like Particles Delivery System Market, by VLP Type
9.1. Introduction
9.2. Bacterial
9.3. Insect
9.4. Mammalian
9.5. Plant
10. Virus-like Particles Delivery System Market, by Delivery Route
10.1. Introduction
10.2. Nasal
10.3. Oral
10.4. Parenteral
10.4.1. Intramuscular
10.4.2. Intravenous
10.4.3. Subcutaneous
11. Virus-like Particles Delivery System Market, by End User
11.1. Introduction
11.2. Hospitals And Clinics
11.3. Pharmaceutical And Biotech Companies
11.4. Research Institutions
11.4.1. Academic Research Institutes
11.4.2. Contract Research Organizations
12. Americas Virus-like Particles Delivery System Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Virus-like Particles Delivery System Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Virus-like Particles Delivery System Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Merck KGaA
15.3.3. Lonza Group Ltd.
15.3.4. Danaher Corporation
15.3.5. Catalent, Inc.
15.3.6. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
15.3.7. Boehringer Ingelheim International GmbH
15.3.8. Wacker Biotech GmbH
15.3.9. Evonik Industries AG
15.3.10. BioVectra Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET: RESEARCHAI
FIGURE 24. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 25. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 26. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY CANCER IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY CANCER IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PROPHYLACTIC VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PROPHYLACTIC VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY INSECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY INSECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 100. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 101. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 104. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 105. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 106. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 107. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 110. CANADA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 120. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 121. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 190. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 191. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 192. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 193. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 196. GERMANY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 204. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 205. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 206. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 207. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 210. FRANCE VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 225. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 228. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 229. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 232. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 233. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 234. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 235. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 238. ITALY VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 246. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 247. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 248. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 249. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 252. SPAIN VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VACCINE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY VLP TYPE, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYSTEM MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA VIRUS-LIKE PARTICLES DELIVERY SYS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Virus-like Particles Delivery System market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Lonza Group Ltd.
  • Danaher Corporation
  • Catalent, Inc.
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Boehringer Ingelheim International GmbH
  • Wacker Biotech GmbH
  • Evonik Industries AG
  • BioVectra Inc.

Related Topics

Related Reports

Chikungunya Market - Global Forecast 2025-2032 - Product Image

Chikungunya Market - Global Forecast 2025-2032

  • Report
  • 186 Pages
  • Global
From
Influenza Market 2025 - Product Image

Influenza Market 2025

  • Report
  • 188 Pages
  • Global
From
Human Papillomavirus (HPV) Cytomegalovirus (CMV) Therapeutic Global Market Report 2025 - Product Image

Human Papillomavirus (HPV) Cytomegalovirus (CMV) Therapeutic Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Zika Virus Infection - Pipeline Insight, 2025 - Product Image

Zika Virus Infection - Pipeline Insight, 2025

  • Clinical Trials
  • 50 Pages
  • Global
From
Covid-19 - Pipeline Insight, 2025 - Product Image

Covid-19 - Pipeline Insight, 2025

  • Drug Pipelines
  • 450 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.